Analysts Set LivaNova PLC (NASDAQ:LIVN) Price Target at $64.40

Shares of LivaNova PLC (NASDAQ:LIVN) have been assigned a consensus recommendation of “Hold” from the five research firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $64.40.

A number of equities analysts have recently commented on the stock. Barclays lifted their price target on shares of LivaNova from $57.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, February 26th. Robert W. Baird increased their price target on LivaNova from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, February 22nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $72.00 price objective on shares of LivaNova in a research note on Wednesday, March 20th. StockNews.com raised shares of LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, Mizuho reaffirmed a “buy” rating and issued a $75.00 price objective on shares of LivaNova in a research note on Wednesday, March 27th.

Institutional Investors Weigh In On LivaNova

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Headlands Technologies LLC acquired a new stake in shares of LivaNova in the 3rd quarter valued at about $72,000. Picton Mahoney Asset Management bought a new stake in shares of LivaNova during the third quarter valued at approximately $91,000. Vanguard Personalized Indexing Management LLC bought a new position in shares of LivaNova in the 3rd quarter worth $217,000. AlphaMark Advisors LLC bought a new stake in LivaNova during the 3rd quarter valued at $244,000. Finally, Jump Financial LLC acquired a new position in LivaNova during the third quarter worth $273,000. 97.64% of the stock is owned by institutional investors.

LivaNova Trading Up 0.8 %

Shares of LIVN stock opened at $55.53 on Monday. The company has a quick ratio of 2.51, a current ratio of 2.95 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $3.00 billion, a P/E ratio of 173.54 and a beta of 0.89. LivaNova has a twelve month low of $42.75 and a twelve month high of $59.86. The stock’s fifty day simple moving average is $54.13 and its 200 day simple moving average is $50.66.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, February 21st. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.10. LivaNova had a return on equity of 12.23% and a net margin of 1.53%. The company had revenue of $310.10 million during the quarter, compared to the consensus estimate of $287.65 million. During the same quarter in the prior year, the firm posted $0.81 earnings per share. The firm’s revenue was up 12.8% compared to the same quarter last year. As a group, sell-side analysts predict that LivaNova will post 3.01 EPS for the current fiscal year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.